MX2009011388A - Inhibidores de polimerasa y su uso para el tratamiento de tumores. - Google Patents
Inhibidores de polimerasa y su uso para el tratamiento de tumores.Info
- Publication number
- MX2009011388A MX2009011388A MX2009011388A MX2009011388A MX2009011388A MX 2009011388 A MX2009011388 A MX 2009011388A MX 2009011388 A MX2009011388 A MX 2009011388A MX 2009011388 A MX2009011388 A MX 2009011388A MX 2009011388 A MX2009011388 A MX 2009011388A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- tumors
- polymerase inhibitors
- inhibitors
- polymerase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
La invención se refiere a inhibidores de polimerasa, en especial inhibidores de polimerasa alfa y su uso en caso de trastornos del crecimiento celular, en especial enfermedades tumorales, con preferencia queratosis actínicas, basaliomas y/o carcinomas espinocelulares.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07090098A EP1990054A1 (de) | 2007-05-11 | 2007-05-11 | Polymerase-Hemmer und ihre Verwendung zur Behandlung von Tumoren |
EP07090106 | 2007-05-30 | ||
EP07075656 | 2007-07-30 | ||
DE102007041968 | 2007-08-31 | ||
EP07075752 | 2007-09-03 | ||
DE102007044849 | 2007-09-13 | ||
EP07075853 | 2007-09-28 | ||
DE102008003477 | 2008-01-04 | ||
PCT/DE2008/000818 WO2008138327A2 (de) | 2007-05-11 | 2008-05-13 | Polymerase-hemmer und ihre verwendung zur behandlung von tumoren |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011388A true MX2009011388A (es) | 2010-03-30 |
Family
ID=40002671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011388A MX2009011388A (es) | 2007-05-11 | 2008-05-13 | Inhibidores de polimerasa y su uso para el tratamiento de tumores. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110182973A1 (es) |
EP (1) | EP2152273A2 (es) |
JP (1) | JP2010526839A (es) |
CN (1) | CN101808644A (es) |
AU (1) | AU2008250809B2 (es) |
BR (1) | BRPI0810682A2 (es) |
CA (1) | CA2687007A1 (es) |
MX (1) | MX2009011388A (es) |
WO (1) | WO2008138327A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2656615T3 (es) | 2012-10-08 | 2018-02-27 | Dow Global Technologies Llc | Compuestos de organofósforo para espumas de poliuretano retardantes de llama |
CN105884628B (zh) * | 2016-06-06 | 2018-06-29 | 上海工程技术大学 | 2,4-二叔丁基-5-氨基酚的制备方法 |
EP3516020B1 (en) * | 2016-09-20 | 2022-05-25 | LANXESS Corporation | Alkylated 3-hydroxydiphenylamine antioxidants |
CN110054654B (zh) * | 2019-05-27 | 2022-12-27 | 武汉百科药物开发有限公司 | 一种地西他滨中间体α-取代脱氧核糖的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663446A (en) * | 1983-06-27 | 1987-05-05 | Trustees Of The Univ. Of Massachusetts | N2 (phenyl substituted) deoxy guanosine containing compounds |
US5646155A (en) * | 1994-05-12 | 1997-07-08 | University Of Massachusetts Medical Center | Drugs to prevent recurrent herpes virus infections |
RU2111970C1 (ru) * | 1996-06-25 | 1998-05-27 | Иван Игоревич Федоров | 3'-оксимино-2',3'-дидезоксинуклеозиды |
KR101298631B1 (ko) * | 2005-06-07 | 2013-08-30 | 예일 유니버시티 | 엘에프엠에이유 및 엘디티를 사용하여 암 및 다른 증상또는 질환을 치료하는 방법 |
-
2008
- 2008-05-13 EP EP08758070A patent/EP2152273A2/de not_active Withdrawn
- 2008-05-13 CA CA002687007A patent/CA2687007A1/en not_active Abandoned
- 2008-05-13 BR BRPI0810682A patent/BRPI0810682A2/pt not_active IP Right Cessation
- 2008-05-13 MX MX2009011388A patent/MX2009011388A/es not_active Application Discontinuation
- 2008-05-13 AU AU2008250809A patent/AU2008250809B2/en not_active Ceased
- 2008-05-13 WO PCT/DE2008/000818 patent/WO2008138327A2/de active Application Filing
- 2008-05-13 US US12/599,614 patent/US20110182973A1/en not_active Abandoned
- 2008-05-13 JP JP2010507790A patent/JP2010526839A/ja active Pending
- 2008-05-13 CN CN200880015439A patent/CN101808644A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010526839A (ja) | 2010-08-05 |
US20110182973A1 (en) | 2011-07-28 |
EP2152273A2 (de) | 2010-02-17 |
AU2008250809A2 (en) | 2010-04-22 |
WO2008138327A3 (de) | 2009-05-28 |
AU2008250809B2 (en) | 2010-09-30 |
BRPI0810682A2 (pt) | 2016-11-16 |
CA2687007A1 (en) | 2008-11-20 |
AU2008250809A1 (en) | 2008-11-20 |
CN101808644A (zh) | 2010-08-18 |
WO2008138327A9 (de) | 2009-12-30 |
WO2008138327A2 (de) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY163477A (en) | Pyrimidinyl-pyridazinone derivatives | |
TWI367886B (en) | Proteasome inhibitors and methods of using the same | |
PH12015502575B1 (en) | Piperidin-4-yl azetidine derivatives as jak1 inhibitors | |
MD20150085A2 (ro) | Inhibitori ai histon-demetilazelor | |
PH12015501221A1 (en) | Pyrimidinones as pi3k inhibitors | |
IL182423A0 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
UA95934C2 (ru) | Производные пиридиазинона для лечения опухолей | |
MX2011010908A (es) | Anticuerpos anti-tnf-alfa y sus usos. | |
IL200793A0 (en) | Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases | |
JO3134B1 (ar) | مثبطات نشاط akt | |
MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
DE602006018709D1 (de) | Estergebundene geminitensidverbindungen zur verwendung in der gentherapie | |
UA107667C2 (uk) | Лікарські сполуки, що модулюють активність піруваткінази-м2, композиції на їх основі та застосування при лікуванні раку | |
MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
MX2009011346A (es) | Tapentadol para tratamiento de dolor con artritis. | |
NZ609594A (en) | Eph receptor expression in tumor stem cells | |
EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
MX2009011388A (es) | Inhibidores de polimerasa y su uso para el tratamiento de tumores. | |
WO2015067710A3 (en) | Tyrp1, a natural mirna sponge, and its use in managing human melanoma aggressiveness | |
MX2010001582A (es) | Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico. | |
UA110108C2 (xx) | Азетидинові похідні піперидин-4-ілу як інгібітори jak1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |